Librea, Vevencio .

HRN: 23-23-37  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2023
CEFTRIAXONE 1G (VIAL)
06/25/2023
07/02/2023
IV
2g
OD
T/C Partial Small Bowel Obstruction
Waiting Final Action 
06/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/25/2023
07/02/2023
IV
500mg
Q8hrs
T/C Partial Small Bowel Obstruction
Waiting Final Action 
06/25/2023
MEBENDAZOLE 500MG (TAB)
07/03/2023
07/03/2023
PO
500mg
OD
T/C Parasitic Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: